Patent · US Active

Anti-CD47 antibodies and uses thereof

US11787860B2 · kind B2 · utility

0Cited by

3References

21Claims

0Family size

Assignee

CELGENE CORPORATION · US

Inventors

Aaron Sato · Somerville, US
Ryan Stafford · Foster City, US
Junhao Yang · South San Francisco, US

Key dates

Filing date	Oct 29, 2020
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Jul 12, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions, methods and uses involving antibodies that specifically bind to human CD47. Also provided are uses and methods, such as therapeutic methods, diagnostic methods, and methods of making such antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.